Evidence map›Paper›PMID 34327874›Full record

ArticleCancer medicine2021

Inflammatory breast cancer appearance at presentation is associated with overall survival.

Wintana Balema, Diane Liu, Yu Shen, Randa El-Zein, Bisrat G Debeb, Megumi Kai, Beth Overmoyer, Kathy D Miller, Huong T Le-Petross, Naoto T Ueno and 1 more

Abstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wintana BalemaGraduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-5768-2378
Diane LiuDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yu ShenDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Randa El-ZeinDepartment of Radiology, Houston Methodist Cancer Center, Houston, TX, USA.
Bisrat G DebebGraduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Megumi KaiDepartment of Radiation Oncology, Morgan Welch IBC Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Beth OvermoyerDana-Farber Cancer Institute, Boston, MA, USA.
Kathy D MillerIndiana University School of Medicine, Indianapolis, IN, USA.
Huong T Le-PetrossDepartment of Radiation Oncology, Morgan Welch IBC Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-0356-498X
Naoto T UenoGraduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-0166-7275
Wendy A WoodwardGraduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-7935-739X

Funding

State of Texas Grant for Rare and Aggressive Breast CancersSusan G. Komen Training Grant for Reducing Breast Cancer Disparities GTDR17498270
6 · The paper itself

Abstract

backgroundInflammatory breast cancer (IBC) is a clinical diagnosis. Here, we examined the association of a "classic" triad of clinical signs, swollen involved breast, nipple change, and diffuse skin change, with overall survival (OS).

methodBreast medical photographs from patients enrolled on a prospective IBC registry were scored by two independent reviewers as classic (triad above), not classic, and difficult to assign. Chi-squared test, Fisher's exact test, and Wilcoxon rank-sum test were used to assess differences between patient groups. Kaplan-Meier estimates and the log-rank test and Cox proportional hazard regression were used to assess the OS.

resultsWe analyzed 245 IBC patients with median age 54 (range 26-81), M0 versus M1 status (157 and 88 patients, respectively). The classic triad was significantly associated with smoking, post-menopausal status, and metastatic disease at presentation (p = 0.002, 0.013, and 0.035, respectively). Ten-year actuarial OS for not classic and difficult to assign were not significantly different and were grouped for further analyses. Ten-year OS was 29.7% among patients with the classic sign triad versus 57.2% for non-classic (p < 0.0001). The multivariate Cox regression model adjusting for clinical staging (p < 0.0001) and TNBC status (<0.0001) demonstrated classic presentation score significantly associated with poorer OS time (HR 2.6, 95% CI 1.7-3.9, p < 0.0001).

conclusionsA triad of classic IBC signs independently predicted OS in patients diagnosed with IBC. Further work is warranted to understand the biology related to clinical signs and further extend the understanding of physical examination findings in IBC.

Indexed as

AdultAgedAged, 80 and overBreastChemotherapy, AdjuvantFemaleHumansInflammatory Breast NeoplasmsKaplan-Meier EstimateMastectomyMiddle AgedNeoadjuvant TherapyPrognosisProspective Studiesbreast cancerbreast swellingerythemaIBCpeau d'orangerednessskin thickeningT4D

Identifiers

PMID34327874
PMCPMC8446552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.